PT. Dataindo Inti Swakarsa

          PT. Dataindo Inti Swakarsa
Membership | FAQ | About | Contact | Home 

Indonesia Companies - Indonesia Industry Reports - Indonesia Trade Reports - Indonesia Bilateral Reports

Related Reports

Company News
Pyridam’s Sales Increase
Bisnis Indonesia, page B2, 2006-02-03
Although PT Pyridam Farma Tbk’s sales all throughout last year was predicted to rise to around Rp.39 billion from Rp.33.97 billion in 2004, its net profit dropped from Rp.1.3 billion to Rp.1.43 billion. This is because the company did not increase the price of its products at all last year. Therefore, Pyridam will increase the selling price of its products by around 8 percent to 10 percent in the beginning of this year in order to adapt to increasing production costs. The minimum sector wage has also been increased as much as 23 percent this year, giving a 4 percent effect to the company’s total expenses.
Pyridam Farma Will Not Share Dividend This Year, 2003-05-26
Due to the fact that its profit dropped by 91 percent from Rp.437 million in 2003, PT Pyridam Farma did share its dividend for that year. The profit was instead used to develop the business by preparing 10 new products and also establish partnerships with Heksa Parm and Kalbe Group to manufacture pharmaceutical drugs, and with Mezza to manufacture traditional medications.
Pyridam Farma Tbk., PT
Indonesia Company Report
Last Update 1-December-2023
Major Businessline : Pharmaceutical

PT. Dataindo Inti Swakarsa
3rd Floor, Gapura Raya Building
Jl. Bangka Raya No. 4, Pela Mampang Email :
Jakarta 12720, Indonesia
Selective Member’s Information US $ Select All
Address 0.66
Telephone number(s) [1] [14-Nov-22] 0.22
Email [14-Nov-22] 1.00
Website [14-Nov-22] 0.28
Personnel (Commissioner [4], Director [2]) 3.30
Establishment Date 0.77
Tax Number (NPWP) [14-Nov-22] 0.77
Business Activity [14-Nov-22] 0.44
Legality (Ownership Type, Investment Type) 0.39
Number of employees [5-Dec-11] 0.77
Certification(s) [1] 0.50
Authorised Capital [8-May-18] 3.85
Paid Up Capital [8-May-18] 3.85
Banker(s) [2] 1.54
Auditor(s) [1] [27-Feb-07] 1.32
Shareholder(s) [5] 16.50
Number Of Shares 3.30
Share Nominal Value 3.30
Additional Information [21-Nov-07] 0.88
Profit and Loss [2015,2016,2017,2018,2019]
(Net Sales, Cost of Goods Sold, Gross Profit, Operating Expense, Operating Profit (Loss), Other Income (Expense), Profit (Loss) After Tax, Growth)
Balance Sheet [2015,2016,2017,2018,2019]
(Total Assets, Current Assets, Non Current Assets, Other Assets, Total Liabilities, Current Liabilities, Long Term Liabilities, Minority, Shareholder's Equity)
Listing History
(First Issue, Company Listing, Stock Dividen)
Ratios (Times) & Per Share Data [2015,2016,2017,2018,2019]
(PER, PBV, Current Ratio, Debt to Equity, Leverage, Gross Profit Margin, Operating Profit Margin, Net Profit Margin, Inventory Turnover, Total Assets Turnover, ROI, ROE)
Price 100.001.560.000
Payment Method
Credit Card
Bank Transfer in US$
Bank Transfer in RP
Buy Now

Selective Member`s Discount Price
To become a Selective Member
Report Content
PROFIT AND LOSS 2020 2021 2022
Revenue 13,613,840 13,229,085 15,397,484
Cost of Goods N/A N/A N/A
Gross Profit 13,613,840 13,229,085 15,397,484
Net Profit Before Tax 3,139,711 4,528,733 5,123,618
The data above is sample data only
Balance Sheet (In RP Millions) 2020 2021 2022
Total Assets 133,260,087 149,168,842 150,180,752
Non Current Assets 1,888,511 1,935,151 2,024,748
Other Assets 2,885,953 4,075,426 50,103,265
Cash on Hand in Bank 47,751,808 43,551,174 27,213,874
Placement in other Bank 3,697,885 2,558,909 7,344,934
Notes & Securities 48,516,569 57,691,639 10,714,256
Loans 28,329,341 39,280,369 52,778,750
Total Liabilities 120,634,642 135,243,441 134,333,598
Minority 776 990 1,268
Total Deposits 118,251,011 131,985,222 129,555,406
Call Money 796,988 672,224 720,321
Notes Issued 252,202 425,039 652,439
Borrowings 219,652 484,127 525,316
Other Liabilities 1,114,013 1,675,839 2,878,848
Shareholder"s Equity 12,625,445 13,925,401 15,847,154
The data above is sample data only